These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13248731)

  • 21. [Treatment of malignant tumors, especially with nitromin and TEM].
    KOYAMA Y; KUMATORI T; TAKEMASA Y
    Gan; 1953 Sep; 44(2-3):374-6. PubMed ID: 13128202
    [No Abstract]   [Full Text] [Related]  

  • 22. Triethylene melamine in the treatment of neoplastic disease.
    RUNDLES RW; BARTON WB
    Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral triethylene melamine therapy of malignant lymphogranuloma and related conditions].
    VAN DER HEIDE-WESSEL C; GROEN J
    Ned Tijdschr Geneeskd; 1951 Nov; 95(47):3542. PubMed ID: 14919679
    [No Abstract]   [Full Text] [Related]  

  • 24. Triethylene melamine therapy in Hodgkin's and other malignant diseases.
    HANSEN PB; BICHEL J
    Acta radiol; 1951 Dec; 36(6):469-76. PubMed ID: 14902588
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of malignant diseases of the blood with cortisone, triethylene melamine and the trace elements].
    DUBOIS-FERRIERE H
    Schweiz Med Wochenschr; 1951 Dec; 81(50):1235-7. PubMed ID: 14913076
    [No Abstract]   [Full Text] [Related]  

  • 26. Triethylene melamine in the management of far advanced ovarian cancer.
    SYKES MP; RUNDLES RW; PIERCE VK; KARNOFSKY DA
    Surg Gynecol Obstet; 1955 Aug; 101(2):133-40. PubMed ID: 14396722
    [No Abstract]   [Full Text] [Related]  

  • 27. [The therapeutic effect of triethylene melamine in hemoblastosis].
    SCHULZE E; FRANKE R; THIELE FH
    Arztl Wochensch; 1953 Jul; 8(29):690-4. PubMed ID: 13080055
    [No Abstract]   [Full Text] [Related]  

  • 28. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.
    KARNOFSKY DA; BURCHENAL JH; ARMISTEAD GC; SOUTHAM CM; BERNSTEIN JL; CRAVER LF; RHOADS CP
    AMA Arch Intern Med; 1951 Apr; 87(4):477-516. PubMed ID: 14810268
    [No Abstract]   [Full Text] [Related]  

  • 29. Triethylene melamine therapy in the lymphomatous diseases.
    RUNDLES RW
    South Med J; 1955 Dec; 48(12):1331-4. PubMed ID: 13274172
    [No Abstract]   [Full Text] [Related]  

  • 30. [Triethylene-melamine and its combinations in therapy of hemolymphoblastosis].
    MARMONT A; FUSCO F
    Arch Maragliano Patol Clin; 1954; 9(5):1179-250. PubMed ID: 13229519
    [No Abstract]   [Full Text] [Related]  

  • 31. [First results of therapy with triethylene melamine].
    NOWOTNA-WALCOWA R
    Pol Tyg Lek (Wars); 1955 Feb; 10(5):149-51. PubMed ID: 14371117
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood].
    BOCK HE; KIRBERGER E; WOELFFER U
    Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291
    [No Abstract]   [Full Text] [Related]  

  • 33. Nasopharyngeal carcinoma. II. Treatment with urethane (ethyl carbamate) and triethylene melamine.
    LAWLEY M; MEKIE DE
    Surg Gynecol Obstet; 1955 Aug; 101(2):141-52. PubMed ID: 14396723
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytotoxic drugs and malignant tumors; action of triethylene melamine, of diethylene-dipropryloxy-benzoquinone and of thiophosphoramide].
    RAVINA A; PESTEL M
    Presse Med (1893); 1958 Mar; 66(17):371-4. PubMed ID: 13542572
    [No Abstract]   [Full Text] [Related]  

  • 35. Triethylene melamine in the treatment of Hodgkin's disease and allied neoplasms.
    RHOADS CP; KARNOFSKY DA; BURCHENAL JH; CRAVER LF
    Trans Assoc Am Physicians; 1950; 63():136-46. PubMed ID: 14855568
    [No Abstract]   [Full Text] [Related]  

  • 36. [Triethylenemelamine in the treatment for malignant neoplasms: review of the literature and 36 personal cases].
    CLOSON J
    Acta Gastroenterol Belg; 1956 Jul; 19(7):521-42. PubMed ID: 13354235
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of leukemia and lymphomata with triethylene melamine.
    WALSH JR; PRATT PT; GRAHAM WE; ZIMMERMAN HJ
    Acta Haematol; 1954 Jun; 11(6):329-38. PubMed ID: 13170978
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical contribution to the treatment of various types of hemoblastosis with triethylene melamine].
    CATTANEO O
    G Ital Chemioter; 1954; 1(3-4):557-8. PubMed ID: 14391668
    [No Abstract]   [Full Text] [Related]  

  • 39. Observations on the use of triethylene melamine in Hodgkin's disease.
    DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R
    Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528
    [No Abstract]   [Full Text] [Related]  

  • 40. TRIETHYLENE-MELAMINE.
    Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.